Share

New Data Show Dulaglutide in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes

Dulaglutide significantly improves A1C (average blood sugar concentration over two to three months) when added to ongoing treatment with a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, according to results from AWARD-10, a new Phase 3b clinical study.1 These data were published online first in The Lancet Diabetes & Endocrinology. “I’ve seen in my practice that even with...
Share

Reduced Time in Hypoglycemia Demonstrated in Recent Insulin Pump Trial

Positive results were announced this week from the study of a new insulin pump with a predictive low glucose suspend (PLGS) feature. Data showed that the system achieved the primary outcome of reducing time spent in hypoglycemia compared to sensor-augmented pump therapy alone. The company developing the device, Tandem Diabetes Care, is marketing its new...
Share

2017: A Progress Report

progress report pic As endocrine science continues to be at the forefront of medical research, a wide array of treatment options, therapies, and products has been discovered. For the second year in a row, Endocrine News has compiled 2017’s newest items to treat a variety of endocrine disorders. As the Endocrine Society wrapped up its first century in...
Share

Pivotal Clinical Validation Data Presented for Upgraded Test at World Congress on Thyroid Cancer

Enhanced classifier identifies 30% more benign patients than original, flagship test Data from a clinical validation study presented at the 3rd World Congress on Thyroid Cancer (WCTC), held July 27-30 in Boston, Mass., demonstrate a next-generation version of a test widely used in thyroid cancer diagnoses can identify 30% more benign thyroid nodules among those...
Share

WellDoc/AADE Partner to Promote Digital Diabetes Self-Management Platform

The American Association of Diabetes Educators (AADE), announced today they will partner with digital healthcare company WellDoc to incorporate the “AADE Diabetes Education Curriculum: A Guide to Successful Self-Management” in the BlueStar® digital therapeutic platform. BlueStar® is an FDA-cleared digital therapeutic used to help adults living with type 2 diabetes self-manage their condition. This partnership...
Share

2016: A Progress Report

progress_shutterstock_226274737 Endocrine science has been at the forefront of research and treatment of a variety of endocrine disorders. The result is a wide array of therapies, products, and more that came to market in 2016, which Endocrine News has compiled here. This past year was the 100th year of the Endocrine Society and it was not...
Share

FDA Grants Clearance for Digital Application for T2D Patients

The U.S. Food and Drug Administration (FDA) today granted 510(k) clearance for a global digital solution that supports the effective management of type 2 adult diabetes patients treated with basal insulin. The application will be marketed as Insulia® by the company Voluntis, which specializes in therapeutic companion software to help patients self-manage chronic diseases. Insulia® Diabetes Management Companion...

The endocrine system is a miracle of evolution — a highly complex machine that carries out multiple functions within the body with precision and efficiency. It’s no wonder that as our understanding of the endocrine system advances, the technology we use to study and care for it also becomes more advanced as it approaches the endocrine system in terms of sophistication. Whether that endocrinology technology takes the form of new, advanced medicines, sophisticated imaging and diagnostic technology, or innovative therapies that make life easier for patients, endocrine science continues to push the boundaries and enter new territory. For endocrinologists, staying informed about all of the latest advances in technology and effective treatment options mean better overall care for their patients.

This section compiles the latest news regarding technological advances in endocrinology, featuring articles written for and by the leading voices in endocrine science today. Here, you’ll find articles relating to all the most recent happenings in technology, techniques and general information of interest to endocrinologists. Keeping up with the latest advancements in the field will help you know where medicine has been, where it will advance next, and how it will look in the future. Endocrine News brings you everything you need to know about the future of endocrinology so you’ll know exactly when science catches up to your patients’ needs. The field of endocrinology continues to advance, and Endocrine News is your source for advancing your own knowledge of everything that’s going on for today and tomorrow.